SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-16-010948
Filing Date
2016-02-16
Accepted
2016-02-16 11:05:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g0216ibiinves_biondvax.htm SC 13G 53847
  Complete submission text file 0001213900-16-010948.txt   55338
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Subject) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: SC 13G | Act: 34 | File No.: 005-89384 | Film No.: 161424673
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 9 AHAD HAAM ST', SHALOM TOWER 26TH FLOOR TEL AVIV L3 6129101
Business Address 9 AHAD HAAM ST', SHALOM TOWER 26TH FLOOR TEL AVIV L3 6129101 97235193444
I.B.I. Investments House Ltd (Filed by) CIK: 0001666605 (see all company filings)

IRS No.: 520034356 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G